- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02059746
Perineal Consequences of Twin Pregnancies According to Mode of Delivery (JUMODA-CP)
This is an ancillary study to the "JUMODA" (National Prospective and Comparative Study on the Mode of Delivery of Twins) study: please see NCT01987063.
The main objective of this study is to investigate the role of the mode of delivery (vaginal versus cesarean) as a risk factor for the occurrence of urinary incontinence at 3 months post-delivery in primiparous women delivering twins after 34 weeks of pregnancy.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The secondary objectives of this study are to compare the following elements between primiparous mothers giving birth to twins vaginally versus by caesarean section after 34 weeks of pregnancy (comparisons will be made at 3 months ant at 12 months post-partum):
A. Diagnosis, type and severity of urinary incontinence via the ICIQ-UI questionnaire
B. Urinary, anorectal and perineal symptoms via the PFDI-20 questionnaire
C. Quality of life related to urinary, anorectal and pelvic floor symptoms via the PFIQ-7 questionnaire
D. Sexuality via the PISQ-12 questionnaire
E. General quality of life via the SF-12 questionnaire
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- CHRU de Montpellier - Hôpital Arnaud de Villeneuve
-
Nîmes, France, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient is available for 12 months of follow-up following delivery
- The patient was included in the JUMODA study
- Primiparous
- Birth of 2 live children after 34 weeks of pregnancy
Exclusion Criteria:
- Adult patient under guardianship
- Patient under judicial protection
- It proves impossible to correctly inform the patient
- Birth occurring before 34 weeks of pregnancy
- Birth not resulting in 2 living children
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Vaginal birth
Patients in the group give birth vaginally. Intervention: Questionnaires sent by mail |
The questionnaires necessary for the study are mailed to patients at 3 and 12 months post-partum.
|
|
Cesaren section
Patients in this group give birth via cesarean section. Intervention: Questionnaires sent by mail |
The questionnaires necessary for the study are mailed to patients at 3 and 12 months post-partum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence/absence of urinary incontinence
Time Frame: 3 months post-partum
|
Defined by a response of 1 to 5 on the first question of the ICIQ-UI questionnaire.
|
3 months post-partum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The ICIQ-UI questionnaire
Time Frame: 3 months post-partum
|
ICIQ-Urinary Incontinence Form
|
3 months post-partum
|
|
The PFDI-20 questionnaire
Time Frame: 3 months post-partum
|
3 months post-partum
|
|
|
The ICIQ-UI questionnaire
Time Frame: 12 months post-partum
|
ICIQ-Urinary Incontinence Form
|
12 months post-partum
|
|
The PFDI-20 questionnaire
Time Frame: 12 months post-partum
|
12 months post-partum
|
|
|
The PFIQ-7 questionnaire
Time Frame: 3 months post-partum
|
3 months post-partum
|
|
|
The PFIQ-7 questionnaire
Time Frame: 12 months post-partum
|
12 months post-partum
|
|
|
The PISQ-12 questionnaire
Time Frame: 3 months post-partum
|
3 months post-partum
|
|
|
The PISQ-12 questionnaire
Time Frame: 12 months post-partum
|
12 months post-partum
|
|
|
The SF-12 questionnaire
Time Frame: 3 months post-partum
|
3 months post-partum
|
|
|
The SF-12 questionnaire
Time Frame: 12 months post-partum
|
12 months post-partum
|
Collaborators and Investigators
Investigators
- Study Director: Renaud de Tayrac, MD, PhD, Centre Hospitalier Universitaire de Nīmes
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urination Disorders
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Pathological Conditions, Signs and Symptoms
- Behavior
- Signs and Symptoms
- Sexual Behavior
- Urinary Incontinence
- Sexuality
Other Study ID Numbers
- AOI/2013/RdeT
- EGY/TDG/AR141876 (Other Identifier: CNIL)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy, Multiple
-
Sheba Medical CenterWithdrawnMultiple PregnancyIsrael
-
Cairo UniversityRiyadh Fertility and Reproductive Health centerCompleted
-
Stanford UniversityCompletedInfertility | Pregnancy, MultipleUnited States, China, Taiwan
-
Aga Khan UniversityVital Pakistan TrustRecruitingMultiple Micronutrient Deficiencies During Pregnancy | Postnatal Growth | Nutrition During Pregnancy | Newborn Health | Neurodevelopment Outcome | Adaptive TrialPakistan
-
University Hospital Virgen de las NievesInstituto de Salud Carlos IIICompletedInfertility | Pregnancy, MultipleSpain
-
Institut Universitari DexeusTerminatedInfertility | Multiple Pregnancy | Oocyte Recipient | Single Embryo Transfer/Double Embryo Transfer | Cumulative Pregnancy RateSpain
-
University of JohannesburgCompletedFetal Congenital Abnormalities | Prolonged Pregnancy | Multiple PregnancySouth Africa
-
Monica Healthcare LtdNew York Presbyterian HospitalTerminatedMultiple Pregnancy | Pre Term LaborUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownLabor Preterm Multiple
-
Sohag UniversityNot yet recruitingMultiple Fractures of Ribs
Clinical Trials on Questionnaires sent by mail
-
University of MichiganCenters for Disease Control and PreventionCompleted
-
University of AarhusUnknown
-
Chang Gung Memorial HospitalTerminated
-
M.D. Anderson Cancer CenterUnknownBreast Cancer | Colorectal Cancer | Prostate CancerUnited States
-
Wills EyeCompleted
-
University Hospital, ToulouseRecruitingBipolar Disorder | Mood Disorder | Idiopathic HypersomniaFrance
-
Southern Medical University, ChinaNot yet recruiting
-
Hasselt UniversityJessa HospitalCompletedHip Pain Chronic | Musculoskeletal Pain | Neck Pain | Low Back Pain, Recurrent | Shoulder Pain | PROMs | Fear of Pain | Musculoskeletal Pain Disorder | Knee Pain Chronic | Fear of InjuryBelgium
-
Pamukkale UniversityCompleted
-
Institut Paoli-CalmettesUnknownHaematologic Disease (Cancer) | Onco-coaching of Sport- InspiratedFrance